Results of a Prospective Study Concerning the Clinical Efficiency of Recent Russian-Made Specialized Foods without Phenylalanine

Background: Specialized foods, based on aminoacids without phenilalanin, are the main source of protein for patients with phenilketonuria of all ages. Based on modern technologies, new Russian-made foods were created. They have an optimized aminoacid and micronutrient composition, which increases their bioavailability.

Objective: Our aim was to investigate the clinical efficiency of the new Russian-made specialized foods based on aminoacids without phenylalanine, in patients with phenylketonuria.

Methods: Evaluating physical, somatic and neuropsychic development as well as measuring phenylalanine blood level were carried out twice: before the prescription and after 1 month of using the new Russian-made specialized foods. The chemical composition of the ration was controlled using dietology methods.

Results: 57 children at the age of 14 days to 15 years with phenylketonuria (which was detected in neonatal screening) were picked for this study. A hypophenylalanine diet has been prescribed for all children no later than at the age of 3 months of life. In children of the first year (I group) (among which there were children with high phenylalanine blood levels) phenylalanine concentration decreased from 5,5 (4,0; 21,0) to 4,4 (3,7; 4,7) mg/dl (p = 0,014) while using Russian-made specialized foods. In this group of children the psychomotor and physical indices improved. In early childhood-, preschool- and school-aged patients phenylalanine blood level remained steady. The chemical composition of the ration with Russian-made foods, based on aminoacids without phenylalanine, corresponded to the reference intake of main nutrients and energy.

Conclusion: Hypophenylalanine diet with new Russian-made specialized foods without phenylalanine (which is designed for phenylketonuria patients of various age groups) showed high clinical efficiency of these foods.

1. Баранов А.А., Боровик Т.Э., Ладодо К.С., и др. Специ али зированные продукты лечебного питания для детей с фенилкетонурией. Методическое письмо. 3-е издание. — М.; 2012. — 84 с. [Baranov AA, Borovik TE, Ladodo KS, et al. Spetsializirovannye produkty lechebnogo pitaniya dlya detei s fenilketonuriei. Metodicheskoe pis’mo. 3th ed. Moscow; 2012. 84 p. (In Russ).]

2. Бушуева Т.В. Диетотерапия при наследственной патологии обмена веществ, выявляемой по неонатальному скринингу: Автореферат дис. д.м.н. — М.; 2016 г. — 44 с. [Bushueva TV. Dietoterapiya pri nasledstvennoi patologii obmena veshchestv, vyyavlyaemoi po neonatal’nomu skriningu. [dissertation abstract] Moscow; 2016. 44 p. (In Russ).]

3. Боровик Т.Э., Ладодо К.С., Бушуева Т.В., и др. Диетотерапия при классической фенилкетонурии: критерии выбора специализированных продуктов без фенилаланина // Вопросы современной педиатрии. — 2013. — Т. 12. — № 5. — С. 40– 48. [Borovik TE, Ladodo KS, Bushueva TV, et al. Dietotherapy of classical phenylketonuria: criteria for choosing specialized phenylalanine-free products. Current pediatrics. 2013;12(5):40–48. (In Russ).] doi: 10.15690/vsp.v12i5.796.

4. Бушуева Т.В. Современный взгляд на проблему фенилкетонурии у детей: диагностика, клиника, лечение // Вопросы современной педиатрии. — 2010. — Т. 9. — № 11. — С. 157–160. [Bushueva TV. Phenylketonuria in children: diagnostics, clinic, treatment. Current pediatrics. 2010;9(11):157–160. (In Russ).]

5. Журба Л.Т., Мастюкова Е.М. Нарушение психомоторного развития детей первого года жизни. — М.: Медицина; 1981. — 272 с. [Zhurba LT, Mastyukova EM. Narushenie psikhomotornogo razvitiya detei pervogo goda zhizni. Moscow: Meditsina; 1981. 272 p. (In Russ).]

6. Студеникин В.М. Нейродиетология детского возраста. — М.: Династия; 2012. — 672 с. [Studenikin VM. Neirodietologiya detskogo vozrasta. Moscow: Dinastiya; 2012. 672 p. (In Russ).]

7. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. Методические рекомендации МР 2.3.1.2432-08. — М.: Федеральный центр гигиены и эпидемиологии Рос потребнадзора; 2009. — 39 с. [Normy fiziologicheskikh potrebnostei v energii i pishchevykh veshchestvakh dlya razlichnykh grupp naseleniya Rossiiskoi Federatsii. Metodicheskie rekomendatsii MR 2.3.1.2432-08. Moscow: Federal’nyi tsentr gigieny i epidemiologii Rospotrebnadzora; 2009. 39 p. (In Russ).]

8. Vockley J, Andersson HC, Antshel KM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188–200. doi: 10.1038/gim.2013.157.

9. Arnold GL, Vladutiu CJ, Kirby RS, et al. Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr. 2002; 141(2):243–246. doi: 10.1067/mpd.2002.126455.

10. Dotremont H, Francois B, Diels M, Gillis P. Nutritional value of essential amino acids in the treatment of adults with phenylketonuria. J Inherit Metab Dis. 1995;18(2):127–130. doi: 10.1007/bf00711746.

11. Koch R, Moseley KD, Yano S, et al. Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment. Mol Genet Metab. 2003;79(2):110– 113. doi: 10.1016/s1096- 7192(03)00078-7.

12. Schindeler S, Ghosh-Jerath S, Thompson S, et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Mol Genet Metab. 2007;91(1):48–54. doi: 10.1016/j.ymgme.2007.02.002.